Metabolic-Fit / 100
GOAL.MD review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Semaglutide: $179/mo monthly; $99/mo with $1,188 annual prepay; tirzepatide: $249/mo monthly; $159/mo with $1,908 annual prepay. Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249.
- Confirm HSA / FSA coverage
- Public signup path reviewed
- Confirm your total cost
GOAL.MD at a glance
- Semaglutide
- $179/mo monthly; $99/mo with $1,188 annual prepay
- Tirzepatide
- $249/mo monthly; $159/mo with $1,908 annual prepay
- Coverage
- Nationwide, per its own site
- Brand-name
- Yes
How we scored GOAL.MD
Every factor comes from GOAL.MD's own published pricing, disclosures and oversight, and the six combine into the 47/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Semaglutide: $179/mo monthly; $99/mo with $1,188 annual prepay; tirzepatide: $249/mo monthly; $159/mo with $1,908 annual prepay. Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249.
What to expect when you sign up
We walked GOAL.MD's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Each product page states the promo and standard price directly: "$X your first month, then $Y/mo"
- 2Free consultation with a licensed U.S. physician
- 3Medications dispensed by licensed U.S. pharmacies
- 4Site states "No auto-billing" for the ongoing charge
What we noticed
- Medically reviewed by a named, NPI-verifiable physician: Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD
- A dedicated "Brand-Name GLP-1 Access" page exists for manufacturer-channel brand medication, though no price is published there
- The headline ad copy leads with the $149/$249 first-month promo rate, not the $199/$299 standard rate — read past the first line
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $179 | Standard monthly$179/mo monthly; $99/mo with $1,188 annual prepay. Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249. |
| Compounded tirzepatide | $249 | Standard monthly$249/mo monthly; $159/mo with $1,908 annual prepay. Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what GOAL.MD's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Semaglutide: $179/mo monthly; $99/mo with $1,188 annual prepay; tirzepatide: $249/mo monthly; $159/mo with $1,908 annual prepay.
- Names an NPI-verifiable physician (Dr. Michael Mimlitz, MD) rather than an anonymous clinical network
- Nationwide, with a separate brand-name-access pathway for FDA-approved medication
The caveats
- Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249.
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
The annual equivalent is not the monthly option
Goal MD lists compounded semaglutide at $179 month to month and tirzepatide at $249. Its lower $99 and $159 monthly equivalents require annual prepayment of $1,188 and $1,908 respectively. The choice is therefore about both the medicine and the commitment. Someone who wants to evaluate a new clinical relationship before paying for a year should compare the $179 or $249 option, rather than assume that the large annual-plan headline is available through separate monthly payments.
The annual totals can make the longer plan attractive on arithmetic alone, but a lower average does not determine whether committing that amount is appropriate. Ask when medication is dispensed, what happens if the prescription changes and how unused treatment is handled if continuation is unsuitable. A year of financial commitment is different from a promise that the same treatment will remain clinically appropriate throughout that year. The written plan should explain both the charge schedule and the response to a change in care.
A named physician is a useful starting point
Goal MD names Dr. Michael Mimlitz, MD, with an NPI that can be used to identify the physician. That is more concrete than a general reference to a network of licensed professionals, but it does not establish that he personally manages every patient or every follow-up. Ask who will assess the application, who remains responsible for the prescription and how a patient reaches that clinician between supplies. An identifiable doctor should help clarify the clinical relationship rather than become a substitute for understanding it.
A separate pathway exists for FDA-approved brand medication without a published price. That route should be evaluated independently from the compounded semaglutide and tirzepatide amounts. It may involve a different pharmacy bill or care arrangement, and a brand listing does not guarantee access to a requested product. Obtain the proposed medication, dose and total charge before comparing it with a compounded annual plan. Research or labeling attached to an approved finished medicine should not be transferred automatically to Goal's compounded preparation.
The practical choice extends beyond the price table
The company describes nationwide availability. Confirm the selected prescription and the patient's actual consultation and delivery locations, especially if travel or a move is expected during an annual purchase. A national marketing statement is most useful when the clinical and dispensing arrangements can be identified for the particular order. Ask which pharmacy prepares the medicine, what formulation it supplies and how changes are communicated. A familiar ingredient name does not mean every pharmacy uses the same concentration or instructions.
Goal MD's public material does not explain pregnancy, breastfeeding, postpartum recovery or PCOS care in depth. A mother whose needs involve those issues should discuss them directly and establish how the service coordinates with existing clinicians. Cancellation and refund rules deserve equal clarity before a prepaid purchase: stopping future renewal does not necessarily recover money already committed. Goal MD is easiest to assess through its readable monthly-versus-annual distinction and named physician. The strongest purchase decision uses the actual selected term, an identifiable dispensing chain and a credible follow-up plan, rather than the annual equivalent alone.
The bottom line for mothers
Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.
Alternatives to GOAL.MD
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit RxSpan MD57
Metabolic-Fit / 100
RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.
- Visit Eden47
Metabolic-Fit / 100
FDA warning letter #728279 (June 2026), which names Eden's website — read that first. Then read the price twice: the advertised $99 is medication alone, with a required $99-a-month membership on top.
Providers like GOAL.MD
Keep comparing GOAL.MD
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Related reading for mothers
- Does Medicaid Cover Zepbound or Wegovy? What Changes in Pregnancy and Postpartum
- GLP-1s and Pregnancy: What to Know if You're Planning — or if You Conceive While on One
- Can You Inject a GLP-1 Into a Stretch Mark? What the Anatomy Says and the Research Has Not Asked
- Constipation on a GLP-1: The One Side Effect That Doesn't Climb With Your Dose
GOAL.MD, answered
- Is GOAL.MD's $149/mo price the real ongoing rate?
- Semaglutide: $179/mo monthly; $99/mo with $1,188 annual prepay; tirzepatide: $249/mo monthly; $159/mo with $1,908 annual prepay. Annual prepayment lowers the equivalents to $99 and $159 per month, while month-to-month plans cost $179 and $249.
- Does GOAL.MD offer brand-name Wegovy or Zepbound?
- It has a dedicated "Brand-Name GLP-1 Access" page for manufacturer-channel medication, but no price is published there as of our review — ask directly before assuming a number.
Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.